OTHERS | HPV 9-in-1 Vaccine
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect women against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV.
- Prevent the four most prevalent high-risk and carcinogenic HPV types (HPV 16, 18, 52, 58) in Hong Kong *
- Prevent high-risk HPV types 16, 18, 31, 33, 45, 52, 58 (causing a total of 90% of cervical cancer), lower the risk of passing above high-risk HPV types to partner and thus the incidence of cervical (pre) cancer
- Reduce 90-95% of the risk for anal cancer
- Reduce 90% of the risk for genital warts
For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6–12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
For persons 15 through 26 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
The appropriate dosing schedule will be determined by the CLINIC's professional.
To book your complimentary consultation with our experts, please fill in our secure online appointment request form below or contact the CLINIC today by calling +852 2538 8868.